Altered expression of miR-375 and miR-541 in type 2 diabetes patients with and without coronary artery disease (CAD): the potential of miR-375 as a CAD biomarker.
Parisa SangaliSara AbdullahiMani NosratiOmeh Farveh Khosravi-AsramiAbdolkarim MahroozAbouzar BagheriPublished in: Journal of diabetes and metabolic disorders (2024)
Our results indicated that circulating levels of miR-375 and miR-541 were elevated in T2D patients with CAD compared to those without CAD. This suggests that miR-375 could potentially be used as a non-invasive biomarker for the diagnosis of CAD in T2D patients.
Keyphrases
- coronary artery disease
- cell proliferation
- long non coding rna
- long noncoding rna
- type diabetes
- poor prognosis
- end stage renal disease
- coronary artery bypass grafting
- percutaneous coronary intervention
- chronic kidney disease
- heart failure
- newly diagnosed
- adipose tissue
- left ventricular
- peritoneal dialysis
- prognostic factors
- climate change
- transcatheter aortic valve replacement
- human health